Terms: = Thyroid cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M
32 results:
1. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
[TBL] [Abstract] [Full Text] [Related]
2. Imprint Cytology of Tall Cell Carcinoma with Reversed Polarity of the Breast: A Case Report.
Shinomiya Y; Kouchi Y; Onodera K; Yamamoto H; Harada-Kagitani S; Sakakibara J; Nagashima T; Ikeda JI; Kishimoto T
Acta Cytol; 2024; 68(1):73-79. PubMed ID: 38262369
[TBL] [Abstract] [Full Text] [Related]
3. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/idh2 axis.
Xi Z; Huang H; Hu J; Yu Y; Ma X; Xu M; Ming J; Li L; Zhang H; Chen H; Huang T
J Exp Clin Cancer Res; 2024 Jan; 43(1):22. PubMed ID: 38238853
[TBL] [Abstract] [Full Text] [Related]
4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
5. Identification of potential diagnostic and prognostic biomarkers for papillary thyroid microcarcinoma (PTMC) based on TMT-labeled LC-MS/MS and machine learning.
Li J; Mi L; Ran B; Sui C; Zhou L; Li F; Dionigi G; Sun H; Liang N
J Endocrinol Invest; 2023 Jun; 46(6):1131-1143. PubMed ID: 36418670
[TBL] [Abstract] [Full Text] [Related]
6. Adrenal Cortical Carcinoma and Additional Rare Pathologic Findings in Multi-Organs in a Birt-Hogg-Dubé Syndrome Patient: With an Emphasis on the Molecular Characteristics of Adrenal Cortical Carcinoma.
Kim D; Murvelashvili N; Hamidi O; Jia L
Int J Surg Pathol; 2023 Aug; 31(5):689-694. PubMed ID: 35946080
[TBL] [Abstract] [Full Text] [Related]
7. Meta-analysis of whole-genome gene expression datasets assessing the effects of idh1 and idh2 mutations in isogenic disease models.
Schulten HJ; Al-Adwani F; Saddeq HAB; Alkhatabi H; Alganmi N; Karim S; Hussein D; Al-Ghamdi KB; Jamal A; Al-Maghrabi J; Al-Qahtani MH
Sci Rep; 2022 Jan; 12(1):57. PubMed ID: 34997121
[TBL] [Abstract] [Full Text] [Related]
8. Tall Cell Carcinoma with Reverse Polarity of Breast: Report of a Case with Unique Morphologic and Molecular Features.
Jassim M; Premalata CS; Okaly G; Srinivas C
Turk Patoloji Derg; 2021; 37(2):183-188. PubMed ID: 33021737
[TBL] [Abstract] [Full Text] [Related]
9. Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the idh2 and PIK3CA genes: a case report.
Haefliger S; Muenst S; Went P; Bihl M; Dellas S; Weber WP; Vlajnic T
Mol Biol Rep; 2020 Jun; 47(6):4917-4921. PubMed ID: 32474846
[TBL] [Abstract] [Full Text] [Related]
10. idh mutation in glioma: molecular mechanisms and potential therapeutic targets.
Han S; Liu Y; Cai SJ; Qian M; Ding J; Larion M; Gilbert MR; Yang C
Br J Cancer; 2020 May; 122(11):1580-1589. PubMed ID: 32291392
[TBL] [Abstract] [Full Text] [Related]
11. Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.
Umphlett M; Shea S; Tome-Garcia J; Zhang Y; Hormigo A; Fowkes M; Tsankova NM; Yong RL
BMC Cancer; 2020 Jan; 20(1):47. PubMed ID: 31959133
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemical analysis of idh2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
Pareja F; da Silva EM; Frosina D; Geyer FC; Lozada JR; Basili T; Da Cruz Paula A; Zhong E; Derakhshan F; D'Alfonso T; Wen HY; Giri DD; Hayes MM; Krings G; Bhargava R; Palazzo JP; Rakha EA; Hoda SA; Sanders ME; Collins LC; Schnitt SJ; Chen YY; Weigelt B; Jungbluth AA; Reis-Filho JS; Brogi E
Mod Pathol; 2020 Jun; 33(6):1056-1064. PubMed ID: 31896809
[TBL] [Abstract] [Full Text] [Related]
13. The cancer driver genes idh1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
14. The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
Hummel S; Kohlmann W; Kollmeyer TM; Jenkins R; Sonnen J; Palmer CA; Colman H; Abbott D; Cannon-Albright L; Cohen AL
BMC Cancer; 2019 Mar; 19(1):190. PubMed ID: 30823903
[TBL] [Abstract] [Full Text] [Related]
15. Diffuse low grade glioma after the 2016 WHO update, seizure characteristics, imaging correlates and outcomes.
Roberts M; Northmore T; Shires J; Taylor P; Hayhurst C
Clin Neurol Neurosurg; 2018 Dec; 175():9-15. PubMed ID: 30292978
[TBL] [Abstract] [Full Text] [Related]
16. Breast Tumor Resembling the Tall Cell Variant of Papillary thyroid Carcinoma: Molecular Characterization by Next-Generation Sequencing and Histopathological Comparison With Tall Cell Papillary Carcinoma of thyroid.
Zhong E; Scognamiglio T; D'Alfonso T; Song W; Tran H; Baek I; Hoda SA
Int J Surg Pathol; 2019 Apr; 27(2):134-141. PubMed ID: 30227763
[TBL] [Abstract] [Full Text] [Related]
17. Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting idh2 and PIK3CA: a validation cohort.
Lozada JR; Basili T; Pareja F; Alemar B; Paula ADC; Gularte-Merida R; Giri DD; Querzoli P; Cserni G; Rakha EA; Foschini MP; Reis-Filho JS; Brogi E; Weigelt B; Geyer FC
Histopathology; 2018 Aug; 73(2):339-344. PubMed ID: 29603332
[TBL] [Abstract] [Full Text] [Related]
18. Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.
Popławski P; Wiśniewski JR; Rijntjes E; Richards K; Rybicka B; Köhrle J; Piekiełko-Witkowska A
PLoS One; 2017; 12(12):e0190179. PubMed ID: 29272308
[TBL] [Abstract] [Full Text] [Related]
19. Contribution of industrial density and socioeconomic status to the spatial distribution of thyroid cancer risk in Hangzhou, China.
Fei X; Lou Z; Christakos G; Liu Q; Ren Y; Wu J
Sci Total Environ; 2018 Feb; 613-614():679-686. PubMed ID: 28938210
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.
Li G; Guo X; Tang L; Chen M; Luo X; Peng L; Xu X; Wang S; Xiao Z; Yi W; Dai L; Wang J
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2011-2024. PubMed ID: 28664449
[TBL] [Abstract] [Full Text] [Related]
[Next]
